Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income margin | 23.0% | 20.6% | 14.6% | 18.2% | 20.6% | 30.5% | 28.8% | 31.3% | 22.3% | 17.9% | 10.8% | 10.4% | 23.4% | 16.6% | 22.7% | 20.9% | 12.1% | 21.9% | 22.4% | 38.3% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Operating Income margin is 21.7%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Operating Income margin for Bristol-Myers Squibb Company have been 23.2% over the past three years, and 21.9% over the past five years.
As of today, Bristol-Myers Squibb Company's Operating Income margin is 21.7%, which is higher than industry median of 21.7%. It indicates that Bristol-Myers Squibb Company's Operating Income margin is Good.